X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Lupin Ltd with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD vs ACTAVIS (US) - Comparison Results

LUPIN LTD    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LUPIN LTD   ACTAVIS
EQUITY SHARE DATA
    LUPIN LTD
Mar-17
ACTAVIS
Dec-14
LUPIN LTD/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,75018,752-   
Low Rs1,38411,438-   
Sales per share (Unadj.) Rs387.43,376.8-  
Earnings per share (Unadj.) Rs56.6-421.4-  
Cash flow per share (Unadj.) Rs76.8309.8-  
Dividends per share (Unadj.) Rs7.500-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs298.97,324.1-  
Shares outstanding (eoy) m451.58265.90-   
Bonus/Rights/Conversions ESOPS--  
Price / Sales ratio x4.04.5 90.5%   
Avg P/E ratio x27.7-35.8 -77.2%  
P/CF ratio (eoy) x20.448.7 41.8%  
Price / Book Value ratio x5.22.1 254.3%  
Dividend payout %13.20-   
Avg Mkt Cap Rs m707,5134,013,841 17.6%   
No. of employees `00016.821.6 77.7%   
Total wages/salary Rs m28,4950-   
Avg. sales/employee Rs Th10,418.341,568.6 25.1%   
Avg. wages/employee Rs Th1,697.00-   
Avg. net profit/employee Rs Th1,523.0-5,187.3 -29.4%   
INCOME DATA
Net Sales Rs m174,943897,882 19.5%  
Other income Rs m1,065-2,241 -47.5%   
Total revenues Rs m176,008895,641 19.7%   
Gross profit Rs m44,931115,346 39.0%  
Depreciation Rs m9,122194,424 4.7%   
Interest Rs m1,52528,321 5.4%   
Profit before tax Rs m35,349-109,640 -32.2%   
Minority Interest Rs m-720-   
Prior Period Items Rs m830-   
Extraordinary Inc (Exp) Rs m0-8,043 0.0%   
Tax Rs m9,785-5,637 -173.6%   
Profit after tax Rs m25,575-112,046 -22.8%  
Gross profit margin %25.712.8 199.9%  
Effective tax rate %27.75.1 538.4%   
Net profit margin %14.6-12.5 -117.1%  
BALANCE SHEET DATA
Current assets Rs m119,542473,069 25.3%   
Current liabilities Rs m61,206345,006 17.7%   
Net working cap to sales %33.314.3 233.8%  
Current ratio x2.01.4 142.4%  
Inventory Days Days7658 131.0%  
Debtors Days Days9066 135.6%  
Net fixed assets Rs m131,660109,640 120.1%   
Share capital Rs m9030-   
"Free" reserves Rs m134,0730-   
Net worth Rs m134,9761,947,473 6.9%   
Long term debt Rs m56,4781,020,514 5.5%   
Total assets Rs m266,0733,569,077 7.5%  
Interest coverage x24.2-2.9 -841.9%   
Debt to equity ratio x0.40.5 79.8%  
Sales to assets ratio x0.70.3 261.4%   
Return on assets %10.2-2.3 -434.2%  
Return on equity %18.9-5.8 -329.3%  
Return on capital %19.3-3.0 -639.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m60,3780-   
CASH FLOW
From Operations Rs m41,148154,184 26.7%  
From Investments Rs m-25,287-369,175 6.8%  
From Financial Activity Rs m4,332207,423 2.1%  
Net Cashflow Rs m20,193-7,568 -266.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 68.74 Rs / USD

Compare LUPIN LTD With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare LUPIN LTD With: PLETHICO PHARMA  ABBOTT INDIA  FDC LTD.  ORCHID PHARMA LTD  SUVEN LIFE  



Today's Market

Of IPOs, LIC-IDBI Bank Deal, and Top Cues in Focus Today(Pre-Open)

Share markets in India closed marginally higher on Friday last week. All sectoral indices traded in green, with stocks in the IT sector and stocks in the pharma sector, leading the gains.

Related Views On News

LUPIN LTD Announces Quarterly Results (4QFY18); Net Profit Down 305.5% (Quarterly Result Update)

Jul 19, 2018 | Updated on Jul 19, 2018

For the quarter ended March 2018, LUPIN LTD has posted a net profit of Rs 8 bn (down 305.5% YoY). Sales on the other hand came in at Rs 40 bn (down 5.2% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Sintex's Auditor Resigns. How You Can Protect Yourself from Such Stocks(The 5 Minute Wrapup)

Jul 20, 2018

While the attack on the bad corporate governance is an overhang in the near term...this can be a game-changer in the years to come.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

PPF v/s Mutual Funds: Which Is Better?(Outside View)

Jul 10, 2018

PersonalFN highlights the key points of distinction between PPF and mutual funds.

ICICI Pru Mutual Fund Tarakki Karega! - The Unethical Way?(Outside View)

Jul 11, 2018

PersonalFN explains how ICICI Prudential Mutual Fund flouted the norms of related party transactions while subscribing to the IPO of ICICI Securities.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Jul 23, 2018 09:17 AM

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LUPIN LTD 8-QTR ANALYSIS

COMPARE LUPIN LTD WITH

MARKET STATS